United Kingdom Callable Healthcare & Pharmaceuticals Corporate Bond Yields (USD)
Fitted spot curve as of 2026-09-11
https://bondscovery.com/yield-curve/usd-corporate-healthcare-pharmaceuticals-united-kingdom-callable
United Kingdom Callable Healthcare & Pharmaceuticals Corporate Bond Yields (USD) as of 2026-09-11: 10Y at 5.76%, fitted curve 6M–30Y (4.55%–6.18%), 62 bonds. Live chart, constituents and forward rates on bondScovery.
| Maturity | Fitted yield | Forward rate |
|---|---|---|
| 6M | 4.55% | — |
| 9M | 4.62% | 4.93% |
| 12M | 4.71% | 4.93% |
| 18M | 4.83% | 5.16% |
| 2Y | 4.91% | 5.23% |
| 3Y | 5.05% | 5.41% |
| 4Y | 5.18% | 5.68% |
| 5Y | 5.30% | 5.93% |
| 6Y | 5.41% | 6.16% |
| 7Y | 5.51% | 6.36% |
| 8Y | 5.60% | 6.52% |
| 9Y | 5.68% | 6.66% |
| 10Y | 5.76% | 6.77% |
| 15Y | 6.00% | 6.92% |
| 20Y | 6.12% | 6.90% |
| 25Y | 6.16% | 6.74% |
| 30Y | 6.18% | 6.58% |
2Y, 10Y and the 10Y−2Y spread over time
The 2-year yield is 4.91% and the 10-year 5.76%, a 10Y−2Y spread of +84 bp — positively sloped — as of 2026-09-11. The chart and table below track how they have moved.
Fitted 2Y and 10Y yields and their spread, sampled one build date per month. See all inverted curves today →
| Tenor | Latest2026-09-11 | 1m ago2026-08-12 | 2m ago2026-07-13 | 3m ago2026-06-12 | 4m ago2026-05-14 | 5m ago2026-04-14 | 6m ago2026-03-16 |
|---|---|---|---|---|---|---|---|
| 2Y | 4.91% | 4.59% | 4.57% | 4.40% | 4.33% | 4.19% | 4.03% |
| 10Y | 5.76% | 5.45% | 5.31% | 5.23% | 5.14% | 5.03% | 5.02% |
| 10Y − 2Y | +84 bp | +85 bp | +74 bp | +83 bp | +80 bp | +83 bp | +99 bp |
Bonds in this curve
A selection of 30 of the 67 bonds behind this curve, spread across maturities.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| Astrazeneca PLC | 4.66% | 2027-02-26 | 4.80% | US04636NAK90 |
| Glaxosmithkline Capital | 4.52% | 2027-03-12 | 4.32% | US377373AM70 |
| CSL Finance PLC | 4.71% | 2027-04-27 | 3.85% | US12661PAA75 |
| Astrazeneca PLC | 4.58% | 2027-06-12 | 3.12% | US046353AN82 |
| Royalty Pharma PLC | 4.73% | 2027-09-02 | 1.75% | US78081BAJ26 |
| Astrazeneca PLC | 4.91% | 2028-03-03 | 4.88% | US04636NAF06 |
| Glaxosmithkline Capital | 4.86% | 2028-05-15 | 3.88% | US377372AN70 |
| Astrazeneca PLC | 4.84% | 2029-01-17 | 4.00% | US046353AT52 |
| Astrazeneca PLC | 4.95% | 2029-02-26 | 4.85% | US04636NAL73 |
| CSL Finance PLC | 5.37% | 2029-04-27 | 4.05% | USG2584CAB21 |
| Glaxosmithkline Capital | 5.00% | 2029-06-01 | 3.38% | US377373AH85 |
| Glaxosmithkline Capital | 5.17% | 2030-04-15 | 4.50% | US377372AP29 |
| Astrazeneca PLC | 5.11% | 2030-08-06 | 1.38% | US046353AW81 |
| Astrazeneca PLC | 5.35% | 2031-05-28 | 2.25% | US04636NAB91 |
| Royalty Pharma PLC | 5.54% | 2031-09-02 | 2.15% | US78081BAN38 |
| CSL Finance PLC | 5.62% | 2032-04-27 | 4.25% | USG2584CAC04 |
| Astrazeneca PLC | 5.28% | 2033-03-03 | 4.88% | US04636NAH61 |
| Glaxosmithkline Capital | 5.45% | 2033-09-15 | 5.25% | US377372AU14 |
| Astrazeneca PLC | 5.42% | 2034-02-26 | 5.00% | US04636NAN30 |
| Smith & Nephew PLC | 5.77% | 2034-03-20 | 5.40% | US83192PAD06 |
| Royalty Pharma PLC | 5.78% | 2034-09-02 | 5.40% | US78081BAR42 |
| Glaxosmithkline Capital | 5.58% | 2035-04-15 | 4.88% | US377372AQ02 |
| Astrazeneca PLC | 5.58% | 2036-03-02 | 4.60% | US04636NAS27 |
| Glaxosmithkline Capital | 5.64% | 2036-09-15 | 5.50% | US377372AV96 |
| Astrazeneca PLC | 5.71% | 2037-09-15 | 6.45% | US046353AD01 |
| Royalty Pharma PLC | 6.11% | 2040-09-02 | 3.30% | US78081BAL71 |
| Glaxosmithkline Capital | 6.03% | 2043-03-18 | 4.20% | US377372AJ68 |
| Astrazeneca PLC | 6.00% | 2045-11-16 | 4.38% | US046353AM00 |
| Astrazeneca PLC | 5.96% | 2050-08-06 | 2.12% | US046353AX64 |
| Royalty Pharma PLC | 6.45% | 2054-09-02 | 5.90% | US78081BAS25 |